Cost-effectiveness analysis of durvalumab plus chemotherapy as first-line treatment for biliary tract cancer

por Ye, Zhuo-miao, Xu, Zhe, Li, Huan, Li, Qian
Publicado 2023

Cost-effectiveness of nivolumab plus ipilimumab as first-line treatment for American patients with unresectable malignant pleural mesothelioma

por Ye, Zhuo-miao, Tang, Zi-Qing, Xu, Zhe, Zhou, Qin, Li, Huan
Publicado 2022

Cost-Effectiveness Analysis of Sintilimab Combined with Chemotherapy Versus Chemotherapy Alone as the First-Line Treatment for Advanced Esophageal Cancer

por Ye, Zhuo-Miao, Xu, Zhe, Zeng, Fan-Yuan, Tang, Zi-Qing, Zhou, Qin
Publicado 2022

A comprehensive evaluation of single nucleotide polymorphisms associated with atrophic gastritis risk: A protocol for systematic review and network meta-analysis

por Tang, Zhen-Yu, Ye, Zhuo-Miao, Zheng, Jing-Hui, Jiang, Feng, Tang, You-Ming
Publicado 2020

m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma

por Wang, Hao-lun, Ye, Zhuo-miao, He, Zi-yun, Huang, Lu, Liu, Zhi-hui
Publicado 2023

A comprehensive assessment of single nucleotide polymorphisms associated with pancreatic cancer risk: A protocol for systematic review and network meta-analysis

por Ye, Zhuo-Miao, Li, Li-Juan, Zheng, Jing-Hui, Zhang, Chi, Lu, Yun-Xin, Tang, Youming
Publicado 2020

A comprehensive evaluation of single nucleotide polymorphisms associated with gastric cancer risk: A protocol for systematic review and network meta-analysis

por Ye, Zhuo-Miao, Hu, Qing-Yu, Zheng, Jing-Hui, Zhang, Chi, Zhu, Xiang-Dong, Tang, You-Ming
Publicado 2020

A comprehensive evaluation of single nucleotide polymorphisms associated with osteosarcoma risk: A protocol for systematic review and network meta-analysis

por Ye, Zhuo-Miao, Luo, Ming-Bo, Zhang, Chi, Zheng, Jing-Hui, Gao, Hong-Jun, Tang, You-Ming
Publicado 2020

Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma

por Zhang, Chi, Zheng, Jing-Hui, Lin, Zong-Han, Lv, Hao-Yuan, Ye, Zhuo-Miao, Chen, Yue-Ping, Zhang, Xiao-Yun
Publicado 2020

Cost‐effectiveness analysis of sintilimab plus IBI305 versus sorafenib for unresectable hepatic cell carcinoma in China

por Xu, Zhe, Ye, Zhuo‐miao, Tang, Yu‐kai, Deng, Dong‐feng, Zhou, Qin, Fang, Man, Zhang, Ying‐ying, Li, Xiang‐ping
Publicado 2023

Cost‐effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first‐line treatment for advanced esophageal cancer

por Ye, Zhuo‐Miao, Xu, Zhe, Wang, Hao‐Lun, Wang, Ying‐Yuan, Chen, Ze‐Chang, Zhou, Qin, Li, Xiang‐Ping, Zhang, Ying‐Ying
Publicado 2022

A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk

por Ye, Zhuo-Miao, Li, Li-Juan, Luo, Ming-Bo, Qing, Hong-Yuan, Zheng, Jing-Hui, Zhang, Chi, Lu, Yun-Xin, Tang, You-Ming
Publicado 2020